000			02103 a2200625 4500
005			20250517055141.0
264		0	_c20160919
008			201609s 0 0 eng d
022			_a2567-689X
024	7		_a10.1160/TH15-06-0497 _2doi
040			_aNLM _beng _cNLM
100	1		_aSeeger, John D
245	0	0	_aSafety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. _h[electronic resource]
260			_bThrombosis and haemostasis _cNov 2015
300			_a1277-89 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aAtrial Fibrillation _xblood
650	0	4	_aBrain Ischemia _xepidemiology
650	0	4	_aCerebral Hemorrhage _xchemically induced
650	0	4	_aComorbidity
650	0	4	_aDabigatran _xadverse effects
650	0	4	_aDatabases, Factual
650	0	4	_aDrug Evaluation
650	0	4	_aEmbolism _xepidemiology
650	0	4	_aFactor Xa Inhibitors _xadverse effects
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aInsurance Coverage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xepidemiology
650	0	4	_aPolypharmacy
650	0	4	_aPropensity Score
650	0	4	_aRetrospective Studies
650	0	4	_aStroke _xetiology
650	0	4	_aThrombophilia _xdrug therapy
650	0	4	_aTreatment Outcome
650	0	4	_aWarfarin _xadverse effects
650	0	4	_aYoung Adult
700	1		_aBykov, Katsiaryna
700	1		_aBartels, Dorothee B
700	1		_aHuybrechts, Krista
700	1		_aZint, Kristina
700	1		_aSchneeweiss, Sebastian
773	0		_tThrombosis and haemostasis _gvol. 114 _gno. 6 _gp. 1277-89
856	4	0	_uhttps://doi.org/10.1160/TH15-06-0497 _zAvailable from publisher's website
999			_c25334356 _d25334356